The UK’s chief scientific adviser has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, prompting claims of a potential conflict of interest. Sir Patrick Vallance, Chief Scientific Adviser to UK Government, was president of GSK 2012 – 2018 Holds a deferred bonus of 43,111 shares worth £600,000 Cashed … Continue reading Revealed: Sir Patrick Vallance has £600,000 shareholding in firm contracted to develop vaccines – The Telegraph